A novel approach to immunization against glioma tumors is described. Immunization against 11 antigens expressed in malignant brain tumors elicits responses to one or more antigens in a large percentage of patients. This novel approach suggests that it could be extended to a phase III trial. Clin Cancer Res; 22(19); 1–3. ©2016 AACR.
See related article by Rampling et al., p. 4776
- Received July 14, 2016.
- Accepted July 19, 2016.
- ©2016 American Association for Cancer Research.